The Top FCA Developments Of 2017
Client Alert | less than 1 min read | 02.02.18
From decisions on small business fraud to interpretations of the reverse FCA, 2017 was another busy year for False Claims Act developments. In a "Feature Comment" published in The Government Contractor, C&M attorneys highlight top developments from 2017 on key issues such as original source requirements, DOJ’s potential dismissal of meritless qui tams, statistical sampling, and perhaps most significantly, the continued evolution of the case law in the wake of the Supreme Court’s landmark implied certification and materiality decision in Escobar.
Contacts
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
